Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Histiocytic Malignant

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Histiocytic Malignant:

Pubmed Logo
Simultaneous aortic body tumor and pulmonary histiocytic sarcoma in a flat-coated retriever.
A case of multiple primary tumors observed in the heart base and in the...
7th November, 2009
Department of Veterinary Medicine, Faculty of Applied Biological Sciences, J Vet Med Sci. 2009 Sep;71(9):1221-3.
[Medical study of 69 cases diagnosed as Kikuchi's disease]
We studied clinical manifestations, laboratory results, treatment,...
23rd October, 2009
Department of Infectious Diseases, Tokyo Metropolitan General Hospital Kansenshogaku Zasshi. 2009 Jul;83(4):363-8.
Disseminated Kikuchi-Fujimoto disease mimicking malignant lymphoma on positron emission tomography in a child.
Kikuchi-Fujimoto disease is a rare and benign disease, characterized by...
23rd September, 2009
Department of Pediatrics, Pyungchon-dong, Dongan-gu, Sacred Heart J Pediatr Hematol Oncol. 2009 Sep;31(9):687-9.
DOI Direct Link
CD13+ anaplastic large cell lymphoma with leukemic presentation and additional chromosomal abnormality.
Anaplastic large cell lymphoma (ALCL) is a highly malignant neoplasm...
18th September, 2009
Department of Pathology and Cytology, University Hospital Center Zagreb, Diagn Cytopathol. 2009 Sep 16.
DOI Direct Link
Evaluation of liposomal clodronate for treatment of malignant histiocytosis in dogs.
Malignant histiocytosis (MH) is an aggressive cancer derived from myeloid...
18th September, 2009
Department of Microbiology, Immunology, and Pathology, Colorado State Cancer Immunol Immunother. 2009 Sep 16.
DOI Direct Link

View more research publications.

Press Releases About Histiocytic Malignant:

BioPortfolio Logo
FDA Advisory Committee Recommends Approval of PEGINTRON(R) for the Adjuvant Treatment of Stage III Malignant Melanoma 5th October, 2009 Schering-Plough Corp.
GAITHERSBURG, Md., Oct. 5, /PRNewswire-FirstCall/ -- Schering-Plough Corp. (NYSE: SGP) announced today that the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC)
JHP Pharmaceuticals Introduces a Dantrium(R) IV (dantrolene sodium for injection), Rapidly Mixing at 20 Seconds 28th September, 2009 JHP Pharmaceuticals, LLC
-- Easier and faster introduction of diluent into the Dantrium® IV vial JHP has also introduced two new features in the Dantrium® IV vial; an easy-to-open flip-off vial cap and an easy-to
Reportlinker Adds World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition, The Report 24th September, 2009 Reportlinker
-- SERMS The report includes market share by type of cancer and market share by company for each of the three major segments. It also includes statistical information for cancers by type
SCHERING-PLOUGH ANNOUNCES FDA APPROVAL OF SAPHRIS(R) (asenapine): for acute treatment of schizophrenia in adults and manic or mixed episodes of bipolar I disorder with or without psychotic features in adults 14th August, 2009 Schering-Plough
Schering-Plough Corporation (NYSE: SGP) today announced that the U.S. Food and Drug Administration (FDA) has approved SAPHRIS(R) (asenapine) sublingual tablets for acute treatment of schizophrenia
MDOUTLOOK(R) Quick Polls Report on Clinical Integration of Key Oncology Developments Following ASCO 2009 24th June, 2009 The Arcas Group
ATLANTA, June 24 /PRNewswire/ -- MDOUTLOOK(R), the innovative oncology intelligence platform, today announced the results from its Quick Poll research, which was launched immediately following this

BioNews Results for Histiocytic Malignant:

RSS Logo
BioPortfolio Logo
Analysis of Factors Influencing Outcome in Patients With In-Transit Malignant Melanoma Undergoing Isolated Limb Perfusion Using Modern Treatment Parameters
MDLinx:  Nov 13 2009 11:06AM Matching: malignant
Analysis of Factors Influencing Outcome in Patients With In-Transit Malignant Melanoma Undergoing Isolated Lim
Journal of Clinical Oncology:  Nov 11 2009 8:40PM Matching: malignant
Lymphangioleiomyomatosis: Cause of a Malignant Chylous Pleural Effusion [Diagnosis in Oncology]
Journal of Clinical Oncology:  Nov 11 2009 8:39PM Matching: malignant
Malignant Transformation in Inflammatory Bowel Disease - Surveillance Guide
MDLinx:  Nov 11 2009 11:00AM Matching: malignant
Some Malignant Tumors Can Be Shut Down After All, CSHL Study Shows
MediLexicon:  Nov 11 2009 5:56AM Matching: malignant
Promote your company here: BioNewsCast - Press Release Distribution

View more news.

BioPortfolio Ltd. offers e-mail and postal lists for Histiocytic Malignant scientists - we have details of around 144 individuals working on Histiocytic Malignant .


This page has been viewed 296 times
Recent Search Terms used to find this page: histiocytosis veterinary research | Compend Contin Educ Vet. 2008 Apr 30 4 202-4 208-16 | Compend Contin Educ Vet. 2008 Apr 30 4 202-4 208-16 | Compend Contin Educ Vet. 2008 Apr 30 4 202-4 208-16 | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Histiocytic Malignant across BioPortfolio, or for Histiocytic Malignant Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.